556 related articles for article (PubMed ID: 17048237)
1. The influence of total mesorectal excision on local recurrence and survival in rectal cancer patients: a population-based study in Greater Amsterdam.
Visser O; Bakx R; Zoetmulder FA; Levering CC; Meijer S; Slors JF; van Lanschot JJ
J Surg Oncol; 2007 May; 95(6):447-54. PubMed ID: 17048237
[TBL] [Abstract][Full Text] [Related]
2. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
Thomschke D; Kyau-Ummen B; Halbfass HJ
Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
[TBL] [Abstract][Full Text] [Related]
3. Factors that influence the adequacy of total mesorectal excision for rectal cancer.
Jeyarajah S; Sutton CD; Miller AS; Hemingway D;
Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969
[TBL] [Abstract][Full Text] [Related]
4. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands.
Kapiteijn E; Putter H; van de Velde CJ;
Br J Surg; 2002 Sep; 89(9):1142-9. PubMed ID: 12190680
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of resection of stage IV rectal cancer with mesorectal excision.
Law WL; Chu KW
J Surg Oncol; 2006 Jun; 93(7):523-8. PubMed ID: 16705728
[TBL] [Abstract][Full Text] [Related]
6. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
[TBL] [Abstract][Full Text] [Related]
7. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
[TBL] [Abstract][Full Text] [Related]
8. The effect of circumferential tumor location in clinical outcomes of rectal cancer patients treated with total mesorectal excision.
Lee SH; Hernandez de Anda E; Finne CO; Madoff RD; Garcia-Aguilar J
Dis Colon Rectum; 2005 Dec; 48(12):2249-57. PubMed ID: 16400512
[TBL] [Abstract][Full Text] [Related]
9. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
[TBL] [Abstract][Full Text] [Related]
10. Surgical outcomes after total mesorectal excision for rectal cancer.
Chiappa A; Biffi R; Bertani E; Zbar AP; Pace U; Crotti C; Biella F; Viale G; Orecchia R; Pruneri G; Poldi D; Andreoni B
J Surg Oncol; 2006 Sep; 94(3):182-93; discussion 181. PubMed ID: 16900534
[TBL] [Abstract][Full Text] [Related]
11. Is postoperative radiotherapy useful for the rectal carcinoma in the era of total mesorectal excision?
Suh KW; Kim BW; Chun M; Lim HY
Hepatogastroenterology; 2002; 49(44):399-403. PubMed ID: 11995460
[TBL] [Abstract][Full Text] [Related]
12. Population-based study of factors influencing occurrence and prognosis of local recurrence after surgery for rectal cancer.
Manfredi S; Benhamiche AM; Meny B; Cheynel N; Rat P; Faivre J
Br J Surg; 2001 Sep; 88(9):1221-7. PubMed ID: 11531871
[TBL] [Abstract][Full Text] [Related]
13. [Recurrence and survival after conventional low anterior resection for rectal cancer].
Bülow S; Moesgaard FA; Crone PO; Gandrup P; Holm J; Kronborg O; Hemmert-Lund H; Myrhøj T; Petersen RH; Qvist N; Raskov HH; Thomsen H
Ugeskr Laeger; 2001 Jul; 163(27):3793-7. PubMed ID: 11466988
[TBL] [Abstract][Full Text] [Related]
14. [Effect of total mesorectal excision and preoperative chemoradiotherapy on local recurrence in rectal cancer].
Wu AW; Gu J; Wang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 May; 9(3):207-9. PubMed ID: 16721678
[TBL] [Abstract][Full Text] [Related]
15. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of recurrence and prognosis after surgical resection for I stage lower rectal carcinoma].
Zhao DB; Bi JJ; Gao JD; Shao YF; Zhao P
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):117-20. PubMed ID: 16555148
[TBL] [Abstract][Full Text] [Related]
17. Is pre-operative radiotherapy necessary in T-T rectal cancer with TME?
Mackay G; Downey M; Molloy RG; O'Dwyer PJ
Colorectal Dis; 2006 Jan; 8(1):34-6. PubMed ID: 16519635
[TBL] [Abstract][Full Text] [Related]
18. Total mesorectal excision for middle and lower rectal cancer: a single institution experience with 337 consecutive patients.
Piso P; Dahlke MH; Mirena P; Schmidt U; Aselmann H; Schlitt HJ; Raab R; Klempnauer J
J Surg Oncol; 2004 Jun; 86(3):115-21. PubMed ID: 15170648
[TBL] [Abstract][Full Text] [Related]
19. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer.
Kim JC; Takahashi K; Yu CS; Kim HC; Kim TW; Ryu MH; Kim JH; Mori T
Ann Surg; 2007 Nov; 246(5):754-62. PubMed ID: 17968166
[TBL] [Abstract][Full Text] [Related]
20. [Factors affecting the prognosis and selection of local excision for low rectal cancer].
Hang JW; Zhou ZX; Bu YQ; Bai XF; Wang X; Zhao P
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):141-3. PubMed ID: 17645854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]